PCSK9 Knockdown Alters Lactylation in Colon Cancer Cells
A proteomics study identifies 1128 differential lactylation sites across 614 proteins in colon cancer cells with PCSK9 knocked down.
Updated on Nov. 19, 2026 in Life Sciences

Researchers used 4D label-free lactylproteomics on PCSK9-knockdown colon cancer cells and identified 1128 differential lactylation sites across 614 proteins. The modifications were mostly downregulated and enriched in glycolytic pathways.
Why it matters
The findings link PCSK9, a protein known for regulating cholesterol, to lactylation of ENO1, a glycolytic enzyme, suggesting a metabolic connection in cancer cells. This points to a possible mechanism that researchers may further examine in colon cancer biology.
The study used 4D label-free lactylproteomics, identifying 1128 differential lactylation sites across 614 proteins in PCSK9-knockdown colon cancer cells, mostly downregulated. Whether these lactylation changes occur in patient tumors or other cell types has not been established.
The details
Using site-directed mutagenesis, researchers generated an ENO1 K71R mutant that abolishes the K71 lactylation site. The mutant showed reduced lactylation, lower enzymatic activity and less lactate production, while PCSK9 knockdown decreased ENO1 activity without changing total ENO1 protein levels.
The Big Picture
Lactylation was first reported in 2019 as a modification linked to lactate-derived signaling, and this study extends that work to a glycolytic enzyme. It connects PCSK9, a regulator of cholesterol metabolism, to the lactylation machinery in colon cancer cells, a link that has not been widely described.
The results are at the basic research stage and do not yet affect treatment or diagnosis. Any future application would depend on follow-up studies testing whether the ENO1 lactylation pathway is relevant in patients.
The takeaway
Metabolic enzymes such as ENO1 can be regulated by protein modifications that link cholesterol-related genes to glycolysis. Readers following cancer research should watch for follow-up work testing whether this pathway holds up in human tumors.
Further reading
Explore more research in Life Sciences for related cellular metabolism studies.
Source note: This article includes information reported by Nature.



